You are here

Biocure Technology Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
CURE
CSE Index: 
Currency: 

 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

You are here

Biocure Technology Inc. (CURE)

SEDAR Information

Biocure Technology Inc.
Date: June 15, 2018
Biocure Technology Inc.
Date: June 15, 2018

Company Info

Address
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Phone
604-609-7146
Fax
N/A
Email
admin@biocuretech.com
Website
http://www.biocuretech.com
Listing date
Monday, May 10, 2010
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
n/a
Auditor
DMCL Chartered Professional Accountants

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
95,597,996
Reserved for Issuance: 

Bulletins

28/11/2017

2017-1117 – Fundamental Change – Gravis Energy Corp./Biocure Technology Inc.

le 28 novembre/November 2017

Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Latest CSE News

Upcoming Events

Blockchain_Revolution_CSE_Website

Blockchain Revolution: The Next Stages

Tuesday, June 19, 2018 (All day)
FISD CSE Website

FISD General Meeting

Thursday, June 21, 2018 -
1:30pm to 7:30pm
International Cannabis Business Conference

International Cannabis Business Conference

Sunday, June 24, 2018 (All day) to Monday, June 25, 2018 (All day)